Hamamatsu Photonics KK engages in the manufacture and sale of imaging and analyzing systems, photomultiplier tubes, imaging devices, light sources, and opto-semiconductors. It operates through the following segments: Electron Tube, Opto-semiconductor, Imaging and Measurement Instruments, and Others. The Electron Tube segment produces photomultiplier tubes, light sources, and imaging devices. The Opto-semiconductor segment offers optical semiconductor devices. The Imaging and Measurement Instruments segment deals with image processing and measurement systems. The Others segment includes semiconductor lasers and hotel businesses. The company was founded by Heihachiro Horiuchi in September 1948 and is headquartered in Hamamatsu, Japan.

Aitia is the leader in the application of Causal AI and Digital Twins to discover the next generation of breakthrough drugs. By leveraging the convergence of multi-omic patient data, high-performance computing, and causal learning and AI, Aitia is revealing the hidden biological mechanisms of disease to create Digital Twins of disease in oncology, neurodegenerative disorders, and immunology. Gemini Digital Twins are being used today to discover novel therapies and accelerate R&D in multiple myeloma, prostate cancer, Alzheimer’s Disease, Parkinson’s Disease, and Huntington’s Disease, with several more in development. Aitia’s partners include seven of the top ten pharmaceutical companies, leading academic research and medical centers, medical societies, leading multi-omic data companies, and patient advocacy groups globally.

Entelos is the leading provider of predictive biosimulation for drug discovery and development. We provide advanced biosimulation capabilities that make discovery more efficient and increase clinical success. For over 15 years, we have enabled R&D organizations to predict better paths to success by simulating systems biology. Our solutions include mechanism-based, mathematical models; virtual patients and populations; biosimulation software; and biosimulation expertise.

The Research Authority serves as the administrative and financial framework for research activities, scientific experiments and technical analyses carried out by Technion faculty, and TRDF staff. The missions of the Research & Development Division are: - Location, collection, processing and distribution of information concerning local and international research funding - Assistance in locating appropriate funding sources for Technion researchers - R&D information management services and in-campus marketing - Guidance and administrative services for Technion researchers in submitting research proposals to granting agencies and business entities - Management of contractual engagements with granting agencies and business entities - Contractual and budgetary administration of research grants and other accounts

Emulate, Inc. owns and operates Organs-on-Chips platform which acts as an automated human bioemulation platform for mimicking true human physiology. The firm's product responses to medicines, chemicals, and diseases can be predicted. The company was founded by James Coon, Donald Ingber and Geraldine Hamilton in July 2014 and is headquartered in Cambridge, MA.

Changshu Intellectual Property Operation Center Co., Ltd., established on 2020-04-20, Business scope includes general items:Trademark agency;copyright agent;Intellectual Property Services;Legal advice(Does not include law firm business);Technology intermediary service;market survey(Does not include foreign investigations);Information Technology Consulting Services;Financial Advisory;Conference and Exhibition Services;graphic design;For-profit private training institutions engaged in scientific and technological training(In addition to the subject classes for primary and middle school students,Language and cultural education and training);HR Services(Excludes job brokerage activities,Labor dispatch service)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Takeda Pharmaceutical Company Ltd (武田薬品工業株式会社 Takeda Yakuhin Kōgyō Kabushiki-gaisha) is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue (top 10 following merger with Shire). The company has over 30,000 employees worldwide and achieved 16.2 billion USD in revenue during the 2012 fiscal year. The company is focused on metabolic disorders, gastroenterology, neurology, inflammation, as well as oncology through its independent subsidiary, Takeda Oncology. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States.

LG Energy Solution Ltd. engages in the manufacturing of storage batteries. It develops advanced automotive batteries, mobility & IT battery, and energy storage systems battery enterprises. The company was founded on December 1, 2020 and is headquartered in Seoul, South Korea.

Xi'an Qingsong Photoelectric Technology Co., Ltd., established on 2010-03-22, The scope of business includes the automatic identification system of human physiological characteristics,Research on large-scale giant electronic display systems and other graphics and image technologies and products,to develop,Production,Sales and Service;Office automation equipment and industrial automation control engineering design,debugging;computer,Network information technology and supporting equipment,computer consumables,Production and sales of electronic components;Computer system integration and software development;property management,Electronic product processing;Design and construction of urban and road lighting projects;Import and export of goods and technology(country restrictions,Excluding goods and technologies that are prohibited and subject to approval for import and export);Design of Electronics and Intelligent Engineering,construction.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Ushio KK engages in the management of retail supermarkets. The company was founded in May 1946 and is headquartered in Izumo, Japan.

Merz Pharma GmbH & Co. KGaA is an innovative and international healthcare company with its own research and development department. It focuses on drugs for the treatment of illness in the fields of neurology and psychiatry. The company is bundling the activities of its subsidiaries Merz Pharmaceuticals, Merz Consumer Care, Merz Dental, and Merz Hygiene, with products ranging from prescription drugs and OTC products for health and wellness, materials for dentists and dental technicians to hygienic products for medical disinfection and cleaning.\nThe units of Merz Group Services, the fith Merz subsidiary, include Human Resources, Supply Chain/Purchasing, Information Technology (IT), Technical Operations and Finances/Controlling.

Cellular Dynamics International Inc., (CDI) is a developer and manufacturer of fully functioning cells in industrial quantities to precise specifications. CDI's proprietary products include true human cells in multiple cell types (iCell products), human induced pluripotent stem cells (iPSCs) and custom iPSCs and iCell products (MyCell Products). CDI's products provide standardized, easy-to-use, cost-effective access to the human cell, the smallest fully functioning operating unit of human biology. Customers use our products, among other purposes, for drug discovery and screening, to test the safety and efficacy of their small molecule and biological drug candidates, for stem cell banking, and in the research and development of cellular therapeutics.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.